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Introduction
The airway epithelium forms the interface between the
respiratory system and the external environment and
consists of ciliated and non-ciliated ceils tightly attached
to each other and to the basement membrane [1]. In
bronchial asthma, areas of airway epithelium become
damaged and the degree of epithelial damage correlates
with the level of bronchial responsiveness [2,3]. Inflam-
matory cells present in the asthmatic airway mucosa may
contribute to the epithelial damage by the production of
oxidants. proteases and cationic proteins [1,3-5]. In
addition, airway epithelium may be disrupted by an
increased subepithelial hydrostatic pressure caused by
oedema of the inflamed airway wall [6]. Several mechan-
isms have been proposed to explain the relationship
between epithelial damage and airway hyperresponsive-
ness. These include, firstly, a reduced production
of epithelium-derived relaxing factors (EpDRF) [7]
and secondly, a decreased metabolization of broncho-
constricting mediators and neurotransmitters by the
damaged epithelial cells [8]. Thirdly, loss of epithelial
integrity may increase airway permeability and provide
easy access of bronchoactive mediators to the airway
smooth muscle [9]. Finally, epithelial damage may
expose intra-epithehal sensory (peptidergic) nerves.
Excitation of these sensory nerves by inflammatory
mediators may lead to a local reflex bronchoconstriction
via release of neuropeptides or tachykinins [10]. The
above-mentioned hypothetical mechanisms are schema-
tically shown in Figure I and will be discussed in some
detail in the present review.
Production of bronchoactivc mediators by the airway
epithelium
After the discovery of endothelium-derived relaxing
factor (EDRF, now identified as nitric oxide [II]) in
blood vessels it was hypothesized that a similar factor
might be produced by the airway epithelium. In asthma.
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this epithelium-derived relaxing factor (EpDRF) might
not be produced in sufficient amounts to keep the airway
smooth muscle in a relaxed state and thereby contribute
to bronchoconstriction. Several candidates for EpDRF
have been put forward including arachidonic acid meta-
bolites [7] and. more recently, NO [12,13].
In vitro, human airway epithelial cells are indeed able
to metabolize arachidonic acid to both cyclooxygenase
and lipoxygenase products [14]. However, the cycloox-
ygenase products thromboxane A^ (TxA;). prostaglan-
din D; (PGD:), and prostaglandin F^,, (PGF;,,,) constrict
human airway smooth muscle both in vivo and in vitro
through activation of the thromboxane prostanoid (TP)-
receptor [15,16]. Prostaglandin E2 (PGE^) and prosta-
glandin li (PGIT . prostacyclin) may relax or contract
airway smooth muscle depending on which prostanoid
receptor subtype is involved [16].
5-Lipoxygenase is the most important enzyme of the
lipoxygenase pathway. It catalyzes the formation of the
unstable leukotriene LTA4 which is further converted to
LTC4, LTD4, and LTE4 [14]. Leukotrienes, especially
LTC4 and LTD4. are potent constrictors of airway and
vascular smooth muscle and increase microvascular per-
meability and mucus secretion [17]. Because all lipoxy-
genase products and most cyclooxygenase products
contrast human airways it is not likely that they act as
EpDRF. Indeed, human isolated airways relax to endo-
genous prostanoids only in the presence of a TP-rcccptor
blocking drug [18].
The highly reactive gas nitric oxide (NO) is formed
from L-arginine by the enzyme NO-synthasc (NOS) which
has been demonstrated in human airway epithelium [W].
NO relaxes smooth muscle through activation of soluble
guanylate cyclase and elevation o'f intracellular cyclic
guanosinemonophosphate(cGMP)[I9]. Recently, it was
suggested that analogous to the vascular endothelium,
the airway epithelium produces NO that may act as
EpDRF [12,13]. In the blood vessels, the NO-producing
endothelium directly lines vascular smooth muscle.
Epithelium-derived NO, however, has to pass a dense
subepithelial vascular plexus to reach airway smooth
muscle.
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Fig. I. Putative mechanisms explaining
the rcIiUionship between cpillielial
damage and airway hyperrcsponsiveness,
EpDRF = epithelium-derived relaxitig
factor.
Because NO eagerly binds to haemoglobin [II] and
relaxes airway smooth muscle only at high concentra-
tions [20]. it is not likely that in vivo epithelial NO
molecules will reach airway smooth muscle in sufficient
amounts to produce airway smooth muscle relaxation.
Indeed, in healthy humans, inhaled NO produces a
potent vasodilation of pulmonary vessels [21] but only
a slight bronchodilation [22]. It can be hypothesized,
therefore, that products released by the airway epithe-
lium may have a more important modulatory role on the
airway mucosal bloodflow than on airway smooth
muscle responsiveness and this may be an important
determinant of airway responsiveness as well.
Metabolic functions of the airway epithelium
The airway epithelium not only provides a physical
barrier restricting access of inhaled noxious stimuli but
also actively defends the underlying submucosa:
bronchoactive peptides like tachykinins and kinins are
degraded by epithelial membrane-bound neutral endo-
peptidase (NEP) and angiotensin-converting enzyme
(ACE) [8.10], Similarly, the neurotransmitter acetyl-
choline and the inflammatory mediator histamine are
inactivated by epithelium-derived acetylcholinesterase
and N-methyltransferase. respectively [23.24]. Oxi-
dants. either inhaled or produced by inflammatory
cells, are inactivated by antioxidants in the epithelial
lining fluid and by the intracellular enzymes superoxide
dismutase, catalase and glutathione peroxidase [25,26].
Airway epithelial cells may also contribute to host
defence by modulating the local mucosal immune
response: Inflammatory cells are recruited into the
airway lumen by chemotactic mediators and cytokines
released by epithelial cells [27,28]. Furthermore, epithelial
cells are able to express specific receptors called adhesion
molecules on their surface which enable them to interact
with migrating inflammatory cells [27.28].
In experimental settings removal of the epithelium or
addition of specific enzytne inhibitors causes hyper-
responsiveness of the airway smooth muscie to
inflammatory mediators, and neurotransmitters which
suggests an important metabolic role of the airway
epithelium [8.18.23]. This is supported by the finding
that viral infections and environmental pollutants such
as cigarette smoke and toluene diisocyanate decrease
epithelial NEP activity and increase airway responsive-
ness [29].
However, airway hyperresponsiveness cannot be
explained by impaired metabolic function of the
damaged epithelium alone. For instance. NEP has also
been demonstrated on sub-epithelial tissues both func-
tionally and by immunohistochemistry [18,30]. More-
over, although asthmatic patients are hypcrresponsivc to
inhaled neuropeptidcs, no evidence for reduction of NEP
activity was found in these patients [31,32] perhaps
because there are sufficient non-epithelial sources of
NEP in the airways. Thus, although the airway epithe-
lium has the potential to act as a metabolic site where
bronchoconstrictive stimuli are inactivated, evidence
that this metabolic function deteriorates in asthma is
lacking.
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Epithelium as a diffusion barrier
The airway epithelium forms a barrier against leakage of
water and solutes into the airways and prevents penetra-
tion of inhaled material to the airway interstitium [6].
This barrier funetion of the epithehum is achieved
through several adhesive mechanisms which are shown
in Figure 2 [1.33]. The desmosome (macula adherens)
and the intermediate junction {/onula adherens) main-
tain cell-to-eell adhesion. Intermediate junctions form a
ring-hke adhesive mechanism around the cell lo which
adhesion molecules have been localized [1,33]. Hemides-
mosomes consist of peptides called integrins and anchor
the basal cells to the basement membrane, The tight
junction (zonula oceludens) is a narrow belt-like struc-
ture of unknown composition surrounding each cell at
the apical pole. Tight junctions are considered as a major
component oi the epithelial barrier and regulate
paracellular transport of large and hydrophilic molecules
[33]. The permeability of tight junctions can be
modulated by proteases, cytokines, eosinophil- and
neutrophil-derived proteins and bacterial products [34].
Because of their important function, evidence of damage
to tight junctions has been sought in disease states like
pulmonary oedema and asthma. In asthmatic patients,
increased airway permeability to inhaled hydrophilic
tracer molecules was found [35] and electronmicro-
scopical studies of bronchial biopsies from asthmatic
patients revealed opening of tight junctions and widening
of intercellular spaces in the airway epithelium [3].
Moreover, the frequency of opening of tight junctions
correlated with eosinophil infiltration and the degree o'(
bronchial responsiveness suggesting a causal relationship
[3]. These observations are supported by studies of
human airways in vitro: luminal exposure of human
airways to oxidants or cationic proteins increased both
airway responsiveness and permeability to the hydro-
philic drugs (Figure 3) [36,37]. Histological examination
of these airways revealed widening of intercellular spaces
and opening of tight junctions in areas that seemed intact
on light microscopical examination (Figure 4) [37].
There are, however, arguments against loss of barrier
function as the main mechanism of bronchial hyperrespon-
siveness. In some studies of bronchial biopsies from asth-
matic patients no structural damage to the airway
epithelium was found although the patients were hyperre-
sponsive to inhaled mcthacholine [38]. Similarly, airway
hyperresponsiveness in laboratory animals exposed to
cationic proteins was caused by the release of bradykinin
and no evidence for epithelial damage was found [39].
Furthermore, although bacterial toxins may increase
tight junction permeability [34], airway hyperresponsive-
ness is not typically found during bacterial pneumonia.
Viral infections, on the other hand, induce airway
hyperresponsiveness [40] and although this has been
attributed to virus-induced epithelial damage, recent
evidence suggests that airway hyperresponsiveness after
viral infections may be related to a deficiency in NO [41].
Finally, studies in guinea-pigs in vivo have shown that a
denuded basement membrane is soon covered by a
plasma-derived gel followed by flattening and migration
of secretory and ciliated epithelial cells over the denuded
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Fig. 2. Schematic representation of the adhesion of the bronchial epithelium.
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Fig. ^. Time courses of the effect of
luminally applied hydrogen peroxide
(HiOi) on permeability of human
isolated airways to '"in-DTPA (n ~ 10).
D = exposure to H;Oi 1 lOmmol I at
T — 90min for 15min. • = controls nol
exposed to H2O2. *P < 0.05 compared
with controls. Reproduced with
permission from Hulsmann vi al. (1996)
[37].
area [6]. Thus, in vivo, the barrier function of the
epithelium may be maintained or restored rapidly after
epithelial damage. However, these repair mechanisms
have not been studied in human airways.
Exposure of intraepithelial sensory nerves with release of
tachykinins
In animal and human airways, superficial unmyeli-
nated sensory nerves (C-fibres or peptidergic nerves)
have been identified that terminate in the airway
epithelium. These nerves contain sensory neuropep-
tides such as the tachykinins substance P (SP) and
neurokinin A (NKA) which may be the neuro-
transmitters of the excitatory non-adrenergic, non-
cholinergic (NANC) nervous system [10,42]. In the
guinea pig, excitation of these nerve fibres by chemical
and physical stimuli may produce retrograde (anti-
dromic) impulses that result in local release of tachy-
kinins (Figure I) [43-45].
Fig. 4. Transmission electron phoiomiLrograph of human bronchial epithelium after exposure to 100 mmol/l H^Oi for 15 min. Open
arrows indicate widening of intercellular spaces; closed arrows depict an opened light junction area, bar — 1 fim. Reproduced witb
permission from Hulsmann ei al. (1996) [37].
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Tachykinins induce airway smooth muscle contrac-
tion, mucus secretion, vascular hyperpermeability and
dilation o^ tiacheal and bronchial blood vessels, and
stimulate and attract inllammatory cells [10,42-45].
Because of these effects, called 'neurogenic inflamma-
tion', tachykinins have been implicated in the pathophy-
siology of asthma. Compared to guinea-pig airways,
however, human airways contain much less tachykinin-
containing nerve fibres [45] and less tachykinin receptors
[46] and this would suggest that in human airways
neurogenic inflammation may be less relevant. Recently,
however, an increased SP-immunoreactivity in broncho-
alveolar fluid and sputum has been reported in asth-
matics [47,48]. Furthermore, inhalation of a tachykinin
receptor antagonist partly prevented bronchoconstric-
tion induced by the C-fibre-stimuIating inflammatory
mediator bradykinin [49].
Althotigh these studies suggest that endogenous tachy-
kinins are released during an asthmatic attack, they do
not prove that these tachykinins are released by nerves
and not, for instance, by inflammatory cells present in
the airways. Therefore, we investigated the effect of
the selective C-fibre-stimulating drug capsaicin [50] on
human isolated airways. Capsaicin caused stnall contrac-
tile responses in human airways. In addition, capsaicin
induced the release of the tachykinins SP and NKA by
these airway preparations, which could be inhibited by
the neural conductance blocker tetrodotoxin (TTX) [51j.
This indicates that the tachykinins were indeed released
by nerve fibres, probably through a local axon reflex
mechanism. Although in our experiments with human
isolated airways these local axon reflexes did not produce
important bronchoconstriction. in vivo local axon
reflexes may produce other features of "neurogenic
inflammation' such as tracheobronchial vasodilatation,
and inflammation and oedema of the airway mucosa.
These processes may increase airway w a^ll thickness and
thereby contribute to airway narrowing [52,53]. Further
studies are necessary to elucidate the relevance of local
axon reflexes in vivo in asthmatic patients.
Conclusiom
From the present experimental evidence, the relationship
between airway epithelial damage and airway hyperre-
sponsiveness cannot be easily attributed to one of the
putative mechanisms mentioned in our introduction.
Firstly, the airway epithelium releases many substances
that may influence airway smooth muscle tone, but the
functional importance of an epithelium-derived relaxing
factor analogous to EDRF.'NO in the vasculature is still
not confirmed in humans. Epithelium-derived factors
may indirectly contribute to airway narrowing by
modulating airway mucosal bloodflow and enhancing
inflammation, Further studies, both in vitro and in vivo,
arc required to confirm this hypothesis.
Secondly, many studies have shown that the airway
epithelium degrades bronchoactive substances. There is,
however, no conclusive evidence for a diminished meta-
bolic function of the airway epithelium in asthma. The
third hypothetical mechanism is supported by the
demonstration of increased permeability of human asth-
matic airways in vivo. Furthermore, epithelial damage
increases both airway responsiveness and permeability oi'
isolated human airways. Sttidies in laboratory animals
suggest maintainence or rapid repair of the barrier
function after epithelial damage in vivo and this process
of epithelial repair should also be investigated in human
airways in vivo.
Finally, recent evidence suggests that local axon reflex
mechanisms which release tachykinins are present in
human airways. The f^unctional relevance of these axon
reflexes for asthmatic airway inflammation and narrow-
ing in vivo remains to be elucidated. From the data
reviewed, it is evident that the human airway epithelium
is a source of many active substances that may influence
airway smooth muscle tone and airway reactivity directly
or indirectly. The precise mechanisms and clinical
relevance of these putative factors require further
investigation.
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